Mon – Fri | 8:00 am – 6:00 pm
Sat – Sun | closed

Tag: Spravato

  • How Often Should You See a Psychiatric Provider?

    How Often Should You See a Psychiatric Provider?

    If you are thinking about taking that first step toward better mental health, it’s normal to have questions about what exactly happens in the process of psychiatric care. We want you to know that it’s brave of you to seek help and prioritize your well-being. Wondering how often you’ll need to see a psychiatric provider is completely normal, and we are here to make it easy for you to understand.


    At Optimum Mental Health Services in Renton, Washington, we believe that mental health care should be personalized for each person. You can be sure that you are not just a number on a list of patients, because all of our providers take a tailor-made approach. Nothing is set in stone when it comes to psychiatric care, because your story, symptoms, and response to treatment are unique to only you.


    For a clearer picture, let’s break down what a typical psychiatric timeline looks like here at Optimum Mental Health Services.

    Phase 1: The Initial Evaluation
    To provide the best possible care, your provider will start your journey by conducting a thorough diagnostic evaluation. This first appointment is incredibly important because it’s how they get to know you, review your medical history, listen to your story, and discuss your personal wellness goals.
    You are heavily involved in what that path looks like. Together, you will collaboratively review all available treatment options. This includes psychiatric medication management if appropriate and a personalized care plan that fits your life.


    Phase 2: Finding Your Balance (Every 1 to 4 Weeks)
    At this point, your provider has prescribed a medication that fits your needs, and you are adjusting to the new routine and dosage. It’s important to meet every week or two during this early stage so we can closely monitor your progress and see how your body responds to the treatment. If you experience any side effects, we are here to help you manage them immediately, making sure you feel supported and have the strength to keep going forward.

    Phase 3: The Stabilization Zone (Every 4 Weeks)
    Once your body adjusts to the prescribed medication, we can reduce the frequency of your appointments. While a monthly check-in is standard during this phase, your exact schedule will be determined in collaboration with your provider to ensure you receive the appropriate level of care.
    This time between appointments allows you to focus on your daily routine and apply the practical coping strategies you discuss during your sessions. Your care team at Optimum Mental Health Services remains available if you require additional medical support between visits.


    Phase 4: Long-Term Maintenance (Every 3 to 6 Months)
    Once your treatment plan is successful, you will transition to long-term maintenance care. Because you are feeling steady, balanced, and confident, you no longer require frequent appointments. However, it is necessary to check in with us every three to six months to evaluate your health, monitor your long-term progress, and renew your prescriptions. These routine appointments are also essential to monitor your stability and prevent your symptoms from recurring.


    Navigating Treatment-Resistant Depression and Spravato® Schedules
    Traditional oral antidepressants do not always provide relief for major depressive disorder. If you have not responded to standard medications, Optimum Mental Health Services offers advanced medical alternatives. We specialize in providing Spravato® (esketamine) nasal spray, an FDA-approved treatment specifically designed for treatment-resistant depression.
    Because patients must take Spravato® under direct medical supervision, your appointment schedule will follow a strict clinical protocol at our Renton office:

    ● Weeks 1 to 4: Two treatment sessions per week.
    ● Weeks 5 to 8: One treatment session per week.
    ● Week 9 and beyond: Maintenance sessions every week or every two weeks, depending on your clinical response.


    Medical studies show that Spravato® can provide rapid relief from depressive symptoms when traditional treatments fail. You do not have to manage persistent depression on your own without options.


    Flexibility Via Telehealth Across Washington State
    Balancing a busy schedule can make it difficult to attend your psychiatric appointments. To help you get consistent care, OPHMS offers flexible telehealth options.
    If you live anywhere in Washington State, you can complete your routine evaluations, follow-up visits, and medication management online. These sessions allow you to speak directly with our providers using a secure, private video platform. Please note that advanced treatments, such as Spravato®, cannot be done virtually and require an in-person visit at our Renton clinic.

    Our Insurance and Self-Pay Pricing Options
    You deserve high-quality mental health care and to make that accessible, Optimum Mental Health Services offers accessible care by partnering with multiple insurance networks. We are currently in-network with:
    ● Aetna
    ● BridgeSpan
    ● Cigna
    ● ComPsych
    ● First Choice Health
    ● HMA (Healthcare Management Administrators)
    ● Kaiser Permanente
    ● LifeWise
    ● Optum
    ● Premera Blue Cross
    ● Providence Health Plan
    ● Regence
    ● TriWest Healthcare Alliance
    ● UnitedHealthcare
    Our administrative staff contacts your insurance company directly to verify your mental health benefits and calculate your exact copayments. We handle the paperwork to ensure your routine care or Spravato® treatments are authorized accurately.


    If you prefer not to use health insurance, we offer direct out-of-pocket self-pay rates:
    ● Initial Evaluation: $300
    ● Follow-Up Appointments: $175

    Contact Optimum Mental Health Services Today
    Whether you prefer an in-person appointment at our Renton office, or you need the flexibility of a telehealth session from home, we are here to support you. Our providers will work directly with you to build a treatment schedule that fits your daily life and clinical needs.
    You can contact our office using the options below to verify your health insurance, ask questions, or set up your initial appointment.
    ● Primary Call or Text Line: (425) 233-0431
    ● Office Address: 15 South Grady Way, Suite 249, Renton, WA 98057
    ● Online Scheduling: Visit our Contact Page to fill out an online inquiry form, and our staff will help you get started.

    FAQs

    Therapy focuses on emotional support, thought patterns, behavior, coping strategies, and structured conversations with a licensed mental health professional. Medication management focuses on psychiatric evaluation, medication planning, symptom monitoring, and treatment follow-up over time.

    Therapy can be a good first step for people seeking support with stress, trauma, anxiety, relationship concerns, emotional regulation, or long-term coping skills. A provider can help determine whether therapy alone or a combination approach makes more sense.

    Medication management may be recommended when symptoms are affecting mood, sleep, focus, daily functioning, or overall stability in ways that require clinical assessment and ongoing monitoring. Recommendations depend on the full evaluation and treatment history.

    GeneSight testing may help support more personalized medication planning by showing how a person’s genetics may affect medication response. It is one part of treatment planning and does not replace evaluation, therapy, or ongoing follow-up care.

    Yes. Many treatment plans combine services such as therapy and medication management, or additional options when clinically appropriate. Integrated care often helps create a more complete and personalized path forward.

  • Debunking common myths about Spravato

    Debunking common myths about Spravato

    Spravato is specifically approved for treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts, meaning it is for individuals who haven’t responded to at least two prior antidepressants. It’s not a last resort but rather an option for those needing a different approach to treatment. There are a lot of misconceptions about Spravato®, and we’re here to clear them up. This FDA-approved treatment for treatment-resistant depression is often misunderstood, leading to confusion about how it works and who it’s for. Let’s break down some myths and uncover the real facts so you can make informed decisions about your mental health.

    MYTH #1 — Spravato is not covered by insurance

    Many insurance plans, including Medicare, do cover Spravato. Our clinic takes care of the entire prior authorization process, working closely with insurers to streamline approvals and ensure a hassle-free experience for our clients.

    While some patients feel relief after just a few sessions, most see gradual changes over several weeks. Depression treatment isn’t one-size-fits-all.

    MYTH #2 — Spravato is only used as a last-resort treatment

    Spravato is specifically approved for treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts, meaning it is for individuals who haven’t responded to at least two prior antidepressants. It’s not a last resort but rather an option for those needing a different approach to treatment.

    MYTH #3 — Spravato works instantly for everyone

    While some patients feel relief after just a few sessions, most see gradual changes over several weeks. Depression treatment isn’t one-size-fits-all.

    MYTH #4 — Spravato is just like taking an antidepressant pill

    Unlike traditional SSRIs and SNRIs, Spravato works on NMDA receptors, offering a unique and faster-acting approach to treatment-resistant depression.

    MYTH #5 — Spravato is addictive like opioids

    While Spravato contains esketamine, a derivative of ketamine, it is not the same as recreational ketamine use and does not lead to physical dependence when used as prescribed. Spravato is administered in a controlled medical setting under supervision, greatly reducing the risk of misuse, and patients are carefully screened before starting treatment to ensure it is an appropriate and safe option.

    MYTH #6 — Spravato replaces the need for therapy or other treatments

    Spravato works best as part of a comprehensive treatment plan. It is not a standalone cure but is most effective when combined with therapy, lifestyle changes, and other medications as needed.

    MYTH #7 — Spravato and IV ketamine therapy are the same

    Both come from ketamine, but Spravato is FDA-approved, administered as a nasal spray, and requires clinical supervision. IV ketamine is not FDA-approved for depression and follows a different protocol.

    MYTH #8 — Spravato is dangerous for everyone with a history of substance use

    While Spravato has the potential for misuse, patients with a history of substance use can still be eligible if properly screened and monitored. Providers assess each patient’s history and develop a treatment plan to ensure safe use.

  • Let’s talk about treatment-resistant depression

    Let’s talk about treatment-resistant depression

    According to a 2021 study, out of the 8.9 million adults who take medication for major depressive disorder, approximately 2.8 million (30.9%) have treatment-resistant depression (TRD). Patients who have not had a positive response to two or more antidepressants from different classes can be considered as having treatment-resistant depression.

    If you have TRD and have not found relief, there is hope.

    image1

    Spravato is transforming the landscape for those with treatment-resistant depression, providing a beacon of hope where other therapies have fallen short. With its innovative approach, many are finding relief and a path toward brighter days.

    In a clinical trial, after four weeks of treatment, about 70% of patients had at least a 50% reduction in symptoms, and about 50% achieved complete remission from depressive symptoms.

    image2

    In a clinical trial, after four weeks of treatment, about 70% of patients had at least a 50% reduction in symptoms, and about 50% achieved complete remission from depressive symptoms.